Year 2023 / Volume 30 / Number 1

PDF HTML

Letter to the Editor

Letter of reply to the article “Updates on the therapeutic approach in complex regional pain syndrome”

Rev. Soc. Esp. Dolor. 2023; 30(1): 63-64 / DOI: 10.20986/resed.2023.4049/2022

César García, Manuel Cortiñas, Beatriz Lechuga, Rafael Galvez






Complete Article

New comment

Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comments

No comments in this article

References

1. Bovaira M, García C, Calvo A, Desé J, Tortosa G, Bayarri V, et al. Actualizaciones en el abordaje terapéutico en el síndrome de dolor regional complejo. Rev Soc Esp Dolor. 2022;29(1):34-50. DOI: 1020986/resed20223978/2022.
DOI: 10.20986/resed.2022.3978/2022
2. Cohen SP, Bhatia A, Buvanendran A, Schwenk ES, Wasan AD, Hurley RW, et al. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):521-46.
DOI: 10.1097/AAP.0000000000000808
3. Kirkpatrick AF, Saghafi A, Yang K, Qiu P, Alexander J, Bavry E, et al. Optimizing the Treatment of CRPS With Ketamine. Clin J Pain. 2020;36(7):516-23.
DOI: 10.1097/AJP.0000000000000831
4. Chitneni A, Patil A, Dalal S, Ghorayeb JH, Pham YN, Grigoropoulos G. Use of Ketamine Infusions for Treatment of Complex Regional Pain Syndrome: A Systematic Review. Cureus. 2021;13(10):e18910.
DOI: 10.7759/cureus.18910
5. Veraart JKE, Smith-Apeldoorn SY, Bakker IM, Visser BAE, Kamphuis J, Schoevers RA, et al. Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review. Int J Neuropsychopharmacol. 2021;24(10):808-31.
DOI: 10.1093/ijnp/pyab039
6. Kutscher E, Greene RE. Ketamine Cystitis: An Underrecognized Cause of Dysuria. J Gen Intern Med. 2022;37(5):1286-9.
DOI: 10.1007/s11606-021-07297-0
7. Cotter S, Wong J, Gada N, Gill R, Jones SC, Chai G, et al. Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case Series. Drug Saf. 2021;44(12):1365-74.
DOI: 10.1007/s40264-021-01120-9
8. Mangnus TJP, Bharwani KD, Stronks DL, Dirckx M, Huygen FJPM. Ketamine therapy for chronic pain in The Netherlands: a nationwide survey. Scand J Pain. 2021;22(1):97-105.
DOI: 10.1515/sjpain-2021-0079

Related articles

Citation tools

García C, Cortiñas M, Lechuga B, Galvez R. Letter of reply to the article “Updates on the therapeutic approach in complex regional pain syndrome”. Rev Soc Esp Dolor 2023; 30(1): 63-64 / DOI: 1020986/resed20234049/2022


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics

This article has received 10050 visits.
This article has been downloaded 0 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 21/12/2022

Accepted: 29/01/2023

Online First: 27/04/2023

Published: 23/05/2023

Article Online First time: 127 days

Article editing time: 153 days


Share

This article hasn't been rated yet.
Reader rating:
Rate this article:
Send by e-mail
© 2025 Revista de la Sociedad Española del Dolor
ISSN: 1134-8046   e-ISSN: 2254-6189

       Indexed in:
Legal Notice